Plasma Cell Neoplasm
📧 Sign up to get email alerts when something new happens for Plasma Cell Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1]
Phase 1 trial of panobinostat in combination with everolimus for relapsed or refractory lymphoma or multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Tipifarnib in Treating Patients With Advanced Hematologic Cancer [Phase 1]
This document reports the status of a Phase 1 clinical trial of tipifarnib for advanced hematologic cancers sponsored by the National Cancer…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders [Phase 1]
A Phase 1 trial evaluating paricalcitol with zoledronate in relapsed or refractory multiple myeloma and other plasma cell disorders was term…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant [Phase 2]
Phase 2 clinical trial evaluating reduction of immunosuppression plus interferon alfa and chemotherapy for post-transplant malignant tumors;…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update describing a conditioning regimen of melphalan, fludarabine, and alemtuzumab followed by peripheral stem cell …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis [Phase 2]
A Phase 2 clinical trial evaluating 4'-Iodo-4'-Deoxydoxorubicin in patients with AL amyloidosis and related plasma cell neoplasms has comple…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [Phase 2]
Phase 2 trial evaluating epoetin alfa for treating chemotherapy-induced anemia in cancer patients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer [NA]
A clinical trial update reports completion of a donor stem cell transplant study in older or frail patients with hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer [Phase 2]
Phase 2 trial evaluating early administration of anti-thymocyte globulin (ATG) followed by cyclophosphamide, busulfan and fludarabine as a c…
-
CLINICAL_TRIALS withdrawal · 2012-07-09Clinical Trial Update: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant [NA]
A clinical trial evaluating mechanical stimulation to prevent bone density loss in patients undergoing donor stem cell transplant has been w…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 3]
Phase 3 trial evaluating melphalan followed by peripheral stem cell transplantation in patients with multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating tocladesine for recurrent or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial of a combination including arsenic trioxide, thalidomide, dexamethasone, and ascorbic acid for relapsed or refractory multip…
-
CLINICAL_TRIALS trial_result · 2011-12-26Clinical Trial Update: Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 trial evaluating sorafenib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma has terminated with results p…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma [Phase 2]
Phase 2 trial evaluating antithymocyte globulin (Thymoglobulin) in patients undergoing stem cell transplantation for multiple myeloma has co…
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating a conditioning regimen of total-body irradiation, busulfan, and interferon alfa before peripheral stem cell or bone…
-
CLINICAL_TRIALS trial_result · 2011-09-01Clinical Trial Update: Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma [NA]
A completed clinical trial evaluated whether ice chips or saline mouth rinse can reduce or prevent mucositis in multiple myeloma patients un…
-
CLINICAL_TRIALS research · 2011-08-04Clinical Trial Update: Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating a chemoprevention therapy for individuals at high risk of developing multiple myeloma; the study status is…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: PS-341 in Treating Patients With Advanced Cancer [Phase 1]
Phase 1 study of PS-341 (bortezomib) in patients with advanced cancer has completed, including leukemia and lymphoma cohorts among the liste…
-
CLINICAL_TRIALS trial_result · 2011-07-27Clinical Trial Update: Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating a three-drug regimen of lenalidomide, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma; resu…
-
CLINICAL_TRIALS trial_result · 2011-07-15Clinical Trial Update: Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated sirolimus, tacrolimus, and methotrexate to prevent acute graft-versus-host disease in patients with he…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by bone marrow or peripheral stem cell transplantation in patients with …
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial of everolimus in relapsed or refractory multiple myeloma has completed; results are reported.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating interferon-gamma or aldesleukin in combination with vaccine therapy for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse [Phase 2]
A Phase 2 study evaluating high-dose melphalan with total-body irradiation followed by peripheral stem cell transplantation for patients wit…